1. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease
   Sandra Pisonero-Vaquero et al, 2015, Mol. Nutr. Food Res. CrossRef
2. NAFLD, Helicobacter species and the intestinal microbiome
   Natalia Castaño-Rodríguez et al, 2017, Best Practice & Research Clinical Gastroenterology CrossRef
3. Effect of Morinda citrifolia (Noni)-Enriched Diet on Hepatic Heat Shock Protein and Lipid Metabolism-Related Genes in Heat Stressed Broiler Chickens
   Joshua Flees et al, 2017, Front. Physiol. CrossRef
4. Pinus densiflora Sieb. et Zucc. Alleviates Lipogenesis and Oxidative Stress during Oleic Acid-Induced Steatosis in HepG2 Cells
   Yu-Jin Hwang et al, 2014, Nutrients CrossRef
5. CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model
   Myong-Min Lee et al, 2018, Phytomedicine CrossRef
6. Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a/XBP1s pathway
   Xinhong Zhu et al, 2018, Food and Chemical Toxicology CrossRef
7. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model
   A-Rang Im et al, 2016, Journal of Medicinal Food CrossRef
8. Crataegus aronia enhances sperm parameters and preserves testicular architecture in both control and non-alcoholic fatty liver disease-induced rats
   Mohammad Dallak, 2018, Pharmaceutical Biology CrossRef
9. Protective Actions of Polyphenols in the Development of Nonalcoholic Fatty Liver Disease
   Yoojin Lee et al, 2019 CrossRef
10. Dietary Interventions in Fatty Liver
    Zahra Yari et al, 2019 CrossRef
11. Flavonoids and Insulin-Resistance: From Molecular Evidences to Clinical Trials
    Benedetta Russo et al, 2019, IJMS CrossRef
12. Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN
    Juan Ji et al, 2015, Sci Rep CrossRef
13. Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype
    Ángela Rojas et al, 2018, Annals of Hepatology CrossRef
14. Black adzuki bean (Vigna angularis) extract exerts phenotypic effects on white adipose tissue and reverses liver steatosis in diet-induced obese mice
    Mina Kim et al, 2017, Journal of Food Biochemistry CrossRef
15. Induction of heme oxygenase-1 with dietary quercetin reduces obesity-induced hepatic inflammation through macrophage phenotype switching
    Chu-Sook Kim et al, 2016, Nutr Res Pract CrossRef
16. Baicalein attenuates impairment of hepatic lysosomal acidification induced by high fat diet via maintaining V-ATPase assembly
    Xinhong Zhu et al, 2019, Food and Chemical Toxicology CrossRef
17. Effects of Quercetin on Improving the Damage Caused by Free Radicals in the Rat Models of Multiple Sclerosis
    Elina Mirzazadeh et al, 2019, Iran South Med J CrossRef
18. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo
    Chen Liang et al, 2020, Pharmacological Research CrossRef
19. Neuroprotective Effect of Quercetin in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Model of Parkinson’s Disease
    Neda Nikokalam Nazif et al, 2019, Shefaye Khatam CrossRef
20. Quercetin supplementation in non-alcoholic fatty liver disease
    Mahboobe Hosseinikia et al, 2020, NFS CrossRef
21. Effect of circulating exosomes derived from normal-weight and obese women on gluconeogenesis, glycogenesis, lipogenesis and secretion of FGF21 and fetuin A in HepG2 cells
    Reza Afrisham et al, 2020, Diabetol Metab Syndr CrossRef
22. Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD-on-a-chip study.
    Manuele Gori et al, 2021, Biotechnol Bioeng CrossRef
23. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
    Samukelisiwe C. Shabalala et al, 2020, Biomedicine & Pharmacotherapy CrossRef
24. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol Levels
    Acharya Balkrishna et al, 2020, Molecules CrossRef
25. Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model
    Wenli Huang et al, 2020, Food & Nutrition Research CrossRef
26. Anthocyanins from the fruits of Lycium ruthenicum Murray improve high-fat diet-induced insulin resistance by ameliorating inflammation and oxidative stress in mice
    Baoming Tian et al, 2021, Food Funct. CrossRef
27. Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21.
    Ghedeir M Alshammari et al, 2021, Biofactors CrossRef
28. Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease
    Luis E. Simental-Mendía et al, 2021 CrossRef
29. Quercetin and non-alcoholic fatty liver disease: A review based on experimental data and bioinformatic analysis
    Li Chen et al, 2021, Food and Chemical Toxicology CrossRef
30. Quercetin enhances fatty acid β-oxidation by inducing lipophagy in AML12 hepatocytes
    Misato Fukaya et al, 2021, Heliyon CrossRef
31. Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism
    Xingtao Zhao et al, 2021, Phytotherapy Research CrossRef
32. The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence
    Huan Yi et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
33. The effects of quercetin on the expression of SREBP-1c mRNA in high-fat diet-induced NAFLD in mice
    Jamal Nasser Saleh Al-maamari et al, 2021 CrossRef
34. Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction
    Pamela Senesi et al, 2021, IJMS CrossRef
35. Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
    Chengyuan Liang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
36. Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
    Maria Sotiropoulou et al, 2021, Saudi J Gastroenterol CrossRef
37. A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?
    Taís Menezes do Moinho et al, 2022, J Mol Med CrossRef
38. Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis
    Antonio Gnoni et al, 2022, IJMS CrossRef
39. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
    Guoyan Jiang et al, 2022, Bioengineered CrossRef
40. Effects of quercetin on the improvement of lipid metabolism through regulating hepatic AMPK and microRNA-21 in high cholesterol diet-fed mice
    Mak-Soon Lee et al, 2022, J Nutr Health CrossRef
41. Pollen and bee bread and liver health
    Zaida Zakaria et al, 2022 CrossRef
42. In-silico reverse docking and in-vitro studies identified curcumin, 18α-glycyrrhetinic acid, rosmarinic acid, and quercetin as inhibitors of α-glucosidase and pancreatic α-amylase and lipid accumulation in HepG2 cells, important type 2 diabetes targets
    Kadima Samuel TSHIYOYO et al, 2022, Journal of Molecular Structure CrossRef
43. The hypoglycemic potential of phenolics from functional foods and their mechanisms
    Oksana Golovinskaia et al, 2023, Food Science and Human Wellness CrossRef
44. Quercetin and polycystic ovary syndrome
    Congshun Ma et al, 2022, Front. Pharmacol. CrossRef
45. Dendrobium mixture ameliorates type 2 diabetes mellitus with non-alcoholic fatty liver disease through PPAR gamma: An integrated study of bioinformatics analysis and experimental verification
    Shuting Zhuang et al, 2023, Front. Pharmacol. CrossRef
46. Bioactive phytochemicals and their potential roles in modulating gut microbiota
    Biying Luo et al, 2023, Journal of Agriculture and Food Research CrossRef
47. A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention
    Paolo Bellavite et al, 2023, Molecules CrossRef
48. Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway
    Havva Afshari et al, 2023, Iran J Pharm Res CrossRef
49. Modulation of lipid metabolism-associated genes by Alternanthera sessilis (red) extracts and identification of potential lipid-lowering phytochemicals using HPLC-QToF-MS/MS
    Cheng Hong Yap et al, 2023, South African Journal of Botany CrossRef
50. Nuciferine ameliorates high‐fat diet‐induced disorders of glucose and lipid metabolism in obese mice based on the gut–liver axis
    Xiangyang Zhu et al, 2023, Food Frontiers CrossRef
51. Chitosan-Carbon nanotube Composite: An approach for controlled release of Quercetin, Modified with carboxymethyl Cellulose, for potential Anti-Cancer therapy
    Fateme Rezaei Abbas Abad et al, 2023, Inorganic Chemistry Communications CrossRef
52. The Negative Impact of Insulin Resistance/Hyperinsulinemia on Chronic Heart Failure and the Potential Benefits of Its Screening and Treatment
    Serafino Fazio et al, 2023, Biomedicines CrossRef
53. Ultrasound-assisted extraction (UAE) and characterization of citrus peel pectin: Comparison between pummelo (Citrus grandis L. Osbeck) and sweet lime (Citrus limetta Risso)
    V. Vathsala et al, 2024, Sustainable Chemistry and Pharmacy CrossRef
54. Targeting dysregulated lipid metabolism in the tumor microenvironment
    Do-Hee Kim et al, 2023, Arch. Pharm. Res. CrossRef
55. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug
    Gaoxuan Shao et al, 2024, Journal of Ethnopharmacology CrossRef
56. Nesfatin-1 and nesfatin-1-like peptide attenuate hepatocyte lipid accumulation and nucleobindin-1 disruption modulates lipid metabolic pathways
    Atefeh Nasri et al, 2024, Commun Biol CrossRef
57. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review
    Zhaolin Sun et al, 2024, Pharmacological Research - Modern Chinese Medicine CrossRef
58. Liposomal quercetin: A promising strategy to combat hepatic insulin resistance and inflammation in type 2 diabetes mellitus
    Sónia Rocha et al, 2024, International Journal of Pharmaceutics CrossRef
59. Flavonoids in Treatment of Chronic Kidney Disease
    Yi-Ling Cao et al, 2022, Molecules CrossRef
60. The hypoglycemic activity of buckwheat and the underlying mechanisms: A mechanistic review
    Xiying Jin et al, 2024, Food Bioscience CrossRef
61. Effects of Gossypetin on Glucose Homeostasis in Diet-Induced Pre-Diabetic Rats
    Karishma Naidoo et al, 2024, Molecules CrossRef
62. Hepatoprotective Effects of Rheum turkestanicum Janisch on High-fat Diet-induced Non-alcoholic Fatty Liver Disease in Mice
    Mohammad Reza Mahdinezhad et al, 2024, LDDD CrossRef
63. Role of selenium and 17 β oestradiol in modulating lipid accumulation in in vitro models of obesity and NAFLD
    Sarah K Walsh et al, 2025 CrossRef
64. Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Julia Markowska et al, 2024, Molecules CrossRef
65. Polysaccharides from Lactarius volemus Fr. ameliorate high-fat and high-fructose diet induced metabolic disorders and intestinal barrier dysfunction
    Hui Xu et al, 2024, International Journal of Biological Macromolecules CrossRef
66. Investigation of Active Components of Meconopsis integrifolia (Maxim.) Franch in Mitigating Non-Alcoholic Fatty Liver Disease
    Qiqin Lu et al, 2024, IJMS CrossRef